Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Minoxidil inside tiny particles can deliver more drug to hair follicles, potentially improving treatment for hair loss.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Menopause can cause skin issues, and seeing a dermatologist helps.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Possible link between androgens and COVID-19 severity; more research needed.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Vismodegib is effective for basal cell carcinoma but has severe side effects.